Induction of apoptosis in human promyelocytic leukemia HL60 cells by panaxynol and panaxydol

• Published in: Molecules (Basel, Switzerland) Vol. 16; no. 7; pp. 5561 - 5573
• Main Authors: Yan, Zhonghong, Yang, Ruolin, Jiang, Yi, Yang, Zhihui, Yang, Junrui, Zhao, Qian, Lu, Yang
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 29.06.2011; MDPI
• Subjects: Apoptosis; Apoptosis - drug effects; Blotting, Western; Cancer; Caspase 3 - metabolism; Cell Cycle - drug effects; Cell death; Cell growth; Cell Survival - drug effects; Diynes - pharmacology; Drug dosages; Fatty Alcohols - pharmacology; Flow Cytometry; HL-60 Cells; Humans; Leukemia; Leukemia, Promyelocytic, Acute - metabolism; Morphology; panaxydol, apoptosis; panaxynol; promyelocytic leukemia cell; China
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules16075561

Panaxynol and panaxydol are naturally occurring polyacetylenes, isolated from the lipophilic fractions of Panax notoginseng, that exert anti-proliferative effects against malignant cells. However, to the best of our knowledge, no study concerning the inhibitory effects of the two polyacetylenes on cell growth of human promyelocytic leukemia cells has been reported. In this paper, we examined the antiproliferation and proapoptotic effects of panaxynol and panaxydol on HL60 cells and investigated their mechanism of action. Cell growth inhibition of panaxynol and panaxydol were determined by trypan blue dye exclusion assays. Apoptosis of cells was revealed by morphological observation, analysis for nuclear DNA distribution and by annexin V-FITC/ PI staining using flow cytometry. It was found that panaxynol and panaxydol markedly inhibited proliferation of HL60 cells in a time- and dose-dependent manner via an apoptotic pathway. In concern with these findings, Western blot analysis showed proteolytic activation of PKCδ, caspase-3 activation and cleavage of poly (ADP [adenosine diphosphate]-ribose) polymerase in HL60 cells treated by panaxynol and panaxydol. In conclusion, panaxynol and panaxydol have profound effects on growth and apoptosis of HL60 cells, suggesting those substances are worthy of further exploration as potential anti-cancer agents.